Home › Paraproteinemias › NCT03616483

The Indiana Myeloma Registry

Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Male or female patients ≥ 18 years of age at the time of informed consent
2. Has been diagnosed with or is suspected to have one of the following:

   1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
   2. Smoldering Multiple Myeloma
   3. Multiple Myeloma
   4. Bony or Soft Tissue Plasmacytoma
   5. Primary Amyloidosis

Exclusion Criteria:

\< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

About the study

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

What is being tested

• This is a non-interventional trial (other)

Sponsor: Indiana University · Participants: 2,500 · Started: Jun 18, 2018

Contact the study team

• Attaya Suvannasankha, MD · Phone: 317-274-0843
• Nisha George, MD · Phone: (317) 274-6635

Official record on ClinicalTrials.gov — NCT03616483

Locations in the U.S.

Conditions

• Paraproteinemias
• Multiple Myeloma
• Monoclonal Gammopathy of Undetermined Significance
• Smoldering Multiple Myeloma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.